TNFSF10 and breast carcinoma: We hypothesized that the LHRss/DOX/TRAIL construct could effectively enhance the cytotoxicity of the drug, promote the apoptotic response, providing a targeted delivery and enhanced effect of DOX and TRAIL to drug-resistant breast cancer cells (Figure 9).